GZMB and neoplasm: At day 28 after tumor challenge, among protected DC-vaccinated mice, CD4+T-subpopulation expressing granzyme B in C-ter-J28+DC recipient splenocytes had increased compared to that in mDC- and TnMUC1-mDC recipient splenocytes, respectively by 69% and 77% (Figure S5B).